浙江震元(000705) - 2017 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2017 was CNY 624,238,757.68, representing a year-on-year increase of 3.38% compared to CNY 602,196,495.46 in the same period last year[8]. - Net profit attributable to shareholders of the listed company reached CNY 10,973,899.66, a significant increase of 35.25% from CNY 8,278,332.14 in the previous year[8]. - The net profit after deducting non-recurring gains and losses was CNY 8,804,607.01, up 32.87% from CNY 7,597,878.58 in the same period last year[8]. - The basic earnings per share (EPS) for the period was CNY 0.0328, reflecting a growth of 34.98% compared to CNY 0.0248 in the previous year[8]. - Net profit increased by 33.61% to ¥11,285,225.09 from ¥8,446,458.13, driven by higher operating income and reduced selling and financial expenses[18]. Assets and Equity - Total assets at the end of the reporting period amounted to CNY 2,100,547,134.58, marking a year-on-year increase of 4.13% from CNY 2,017,140,314.96[8]. - The net assets attributable to shareholders of the listed company were CNY 1,309,887,404.02, an increase of 1.28% compared to CNY 1,293,309,710.08 at the end of the previous year[8]. - Cash and cash equivalents decreased by 31.89% to ¥167,221,901.82 from ¥245,521,805.07 due to the collection period of the parent company's procurement platform and subsidiary operations[15]. - Accounts receivable notes increased by 63.65% to ¥48,710,308.98 from ¥29,764,400.25, mainly due to a reduction in payment for goods[15]. - Prepayments rose by 65.13% to ¥43,780,450.08 from ¥26,512,774.37, primarily due to prepayments for exclusive distribution products[15]. - Other receivables surged by 143.65% to ¥27,695,469.13 from ¥11,366,676.65, attributed to an increase in business reserve funds[15]. Cash Flow - The company reported a net cash flow from operating activities of CNY -49,516,579.48, indicating a decrease compared to CNY -37,875,888.15 in the previous year[8]. - The net cash flow from investing activities was -¥9,679,533.47, significantly improved from -¥96,821,238.76 in the previous year, indicating no cash outflow for investments this period[18]. - The net cash flow from financing activities was -¥20,958,522.08, a decrease from ¥70,355,839.08 in the previous year, reflecting no bank loans this period[18]. Dividends and Financial Expenses - The company reported a 1789.77% increase in dividends payable to ¥7,055,836.25 from ¥373,370.53, primarily due to 2016 dividends[15]. - The financial expenses turned positive at -¥2,382,433.52 compared to -¥89,099.02 in the previous year, mainly due to the accrual of investment fund income[15]. Other Activities - The company has completed a capital increase in Tongyuan Health Management Co., Ltd., making it a subsidiary and included in the consolidated financial statements[9]. - The company has not engaged in any repurchase transactions among the top 10 shareholders during the reporting period[13]. - The company did not engage in any securities or derivative investments during the reporting period[20][22].